Evidence map›Paper›PMID 33865497›Full record

ArticleLancet (London, England)2021

Ten scientific reasons in support of airborne transmission of SARS-CoV-2.

Trisha Greenhalgh, Jose L Jimenez, Kimberly A Prather, Zeynep Tufekci, David Fisman, Robert Schooley

Erratum issuedAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Lancet (London, England), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 408 papers, 9 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
408citing papers in PubMed, 9 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

408 citing papers in PubMed, 9 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. The Risk of Aircraft-Acquired SARS-CoV-2 Transmission during Commercial Flights: A Systematic Review.International journal of environmental research and public health · 2024
    Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Trial
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

348 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Trisha GreenhalghDepartment of Primary Care Health Sciences, University of Oxford, Oxford OX2 6GG, UK. Electronic address: trish.greenhalgh@phc.ox.ac.uk.
Jose L JimenezDepartment of Chemistry and Cooperative Institute for Research in the Environmental Sciences, University of Colorado, Boulder, CO, USA.
Kimberly A PratherScripps Institution of Oceanography, University of California, San Diego, La Jolla, CA, USA.
Zeynep TufekciSchool of Information and Library Science, University of North Carolina, Chapel Hill, NC, USA.
David FismanDalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.
Robert SchooleyDepartment of Medicine, Division of Infectious Diseases and Global Public Health, School of Medicine, University of California San Diego, La Jolla, CA, USA.

Funding

Development of Sustained-Release Anti-HIV Nucleoside Phosphonate NanoparticlesR01AI131424 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SCHOOLEY, ROBERT TURNER · 2017 to 2021
$3.8M
NIAID NIH HHS R01 AI131424NIH HHS AI131424Wellcome TrustWellcome Trust WT104830MA
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Air MicrobiologyEvidence-Based MedicineAerosolsCOVID-19HumansSARS-CoV-2Aerosols

Identifiers

PMID33865497
PMCPMC8049599

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.